RHUMBLINE ADVISERS - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 59 filers reported holding SECOND SIGHT MED PRODS INC in Q2 2016. The put-call ratio across all filers is 0.82 and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q1 2017$13,000
-35.0%
10,989
+6.5%
0.00%
Q4 2016$20,000
-75.3%
10,323
-55.0%
0.00%
Q3 2016$81,0000.0%22,915
+1.8%
0.00%
Q2 2016$81,000
+58.8%
22,515
+114.2%
0.00%
Q1 2016$51,000
-17.7%
10,5120.0%0.00%
Q4 2015$62,00010,5120.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q2 2016
NameSharesValueWeighting ↓
ORACLE INVESTMENT MANAGEMENT INC 431,582$4,428,0000.58%
AWM Investment Company, Inc. 234,965$2,411,0000.33%
DAFNA Capital Management LLC 39,800$408,0000.32%
AYM CAPITAL, LLC 15,193$156,0000.12%
CARL DOMINO INC 20,350$209,0000.11%
JW Asset Management, LLC 8,500$87,0000.06%
NumerixS Investment Technologies Inc 13,800$142,0000.05%
FIDUCIARY TRUST INTERNATIONAL LLC 14,100$145,0000.04%
Cubist Systematic Strategies, LLC 15,711$161,0000.01%
REGIONS FINANCIAL CORP 32,000$328,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders